Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Novel panaxatriol derivative shows efficacy in rat model of MI/R injury

Jan. 27, 2020

Fat or fiber, cFAP activation is problematic for heart

Jan. 27, 2020

FDA approves Ozempic to reduce MACE in adults with type 2 diabetes and heart disease

Jan. 17, 2020

HDAC blockade seen to restore cardiopulmonary function in felines

Jan. 16, 2020

Cynata receives approval for its U.K. phase II study in critical limb ischemia

Jan. 15, 2020

Targeting SMPD1 ameliorates leptin resistance-derived endothelial dysfunction in rats

Jan. 15, 2020

New cardiac sarcomere inhibitors discovered at Cytokinetics

Jan. 14, 2020

Novartis opens phase III study of TQJ-230 in patients with cardiovascular disease

Jan. 14, 2020

AKCEA-TTR-LRx begins phase III cardiovascular outcomes study

Jan. 13, 2020

Merck & Co. discovers PCSK9 inhibitors

Jan. 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...